Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.27) by 3.7 percent. This is a 16.13 percent increase over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $7.21 million which beat the analyst consensus estimate of $6.60 million by 9.17 percent. This is a 28.41 percent increase over sales of $5.61 million the same period last year.